Clinical Trial

Comparison of 0.4% Hyaluronic Acid Solution Versus Hydroxyethylamide Solution in Submucosal Endoscopic Resections

Recruiting
View on ClinicalTrials.gov →
Summary
This is a randomized, single-center clinical trial that will compare the efficacy of two substances used in the submucosal cushion formation stage of endoscopic submucosal resections of early esophageal malignant neoplasms. Such substances are hyaluronic acid in the form of TS-905 Blue Eyeₒ and hydroxyethylamide (Voluven®).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-04; most recent amendment 2026-07-16.
Trial Details
NCT Number NCT06077981
Lead Sponsor Instituto do Cancer do Estado de São Paulo
Conditions Esophageal Neoplasms, Endoscopic Mucosal Resection, Hyaluronic Acid
Enrollment 30 participants
Start Date 2023-06-19
Primary Completion 2024-12-30 (estimated)
Study Completion 2027-01-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-17